Update: 26.03.2024
Last week: 11 week 2024 (11.03.2024 - 17.03.2024)
Last full month: February 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 050 | 11.7% | 10.4% | -0.8 | 17 971 195 | 9.8% | 8.9% | -0.8 | 20.3% |
| MoM | 29 171 | 8.3% | 11.0% | -0.1 | 65 772 614 | 9.3% | 9.5% | -0.1 | 9.6% |
| YTD | 74 693 | 27.5% | 11.0% | 2.4 | 167 765 784 | 60.2% | 9.5% | 2.3 | -0.5% |
| MAT | 356 951 | 35.6% | 9.6% | 1.7 | 719 843 547 | 48.7% | 8.1% | 1.5 | 10.8% |
| BRAINMAX | |||||||||
| WoW | 1 030 | 13.3% | 100.0% | 0 | 3 599 867 | 7.1% | 100.0% | 0 | 13.3% |
| MoM | 3 949 | -7.8% | 100.0% | 0 | 14 394 547 | -5.2% | 100.0% | 0 | -7.8% |
| YTD | 10 656 | 68.7% | 100.0% | 0 | 38 359 137 | 80.0% | 100.0% | 0 | 68.7% |
| MAT | 50 991 | 209.0% | 100.0% | NA | 178 051 328 | 229.3% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 19 276 | 16.7% | 45.0% | 1.4 | 61 208 525 | 18.0% | 36.2% | 0.8 | 13.2% |
| MoM | 68 306 | 1.9% | 43.8% | 0.3 | 217 517 575 | -1.1% | 35.9% | -0.2 | 1.2% |
| YTD | 178 881 | 4.7% | 43.9% | 2.1 | 575 693 042 | 11.8% | 36.1% | -1.7 | -0.5% |
| MAT | 877 004 | 22.2% | 45.4% | 2.2 | 2 752 620 342 | 31.3% | 39.2% | 1.5 | 16.2% |
| MIGRENIUM | |||||||||
| WoW | 12 247 | 0.1% | 0.5% | 0 | 3 745 467 | 2.2% | 0.7% | 0 | 7.3% |
| MoM | 53 054 | 6.6% | 0.6% | 0.1 | 15 088 199 | 15.2% | 0.7% | 0.1 | -6.1% |
| YTD | 132 585 | -0.7% | 0.5% | -0.1 | 37 136 297 | 54.5% | 0.6% | 0.1 | 23.7% |
| MAT | 640 712 | 9.5% | 0.5% | 0 | 135 770 045 | 28.6% | 0.5% | 0 | 15.5% |
| MODELAX-N | |||||||||
| WoW | 36 887 | -2.9% | 26.8% | -2 | 15 435 441 | -2.7% | 17.2% | -1.3 | 4.4% |
| MoM | 129 731 | 8.5% | 23.0% | 2.9 | 53 054 568 | 12.2% | 14.2% | 2.2 | -5.0% |
| YTD | 339 513 | 62.4% | 22.8% | 5.5 | 137 979 492 | 106.7% | 14.0% | 4.1 | 23.1% |
| MAT | 1 298 425 | 127.6% | 19.8% | 9 | 454 039 755 | 140.0% | 11.3% | 5.2 | 24.5% |
| REDUXIN | |||||||||
| WoW | 14 174 | 11.4% | 33.1% | -0.5 | 79 486 350 | 16.5% | 47.0% | 0.5 | 13.2% |
| MoM | 51 307 | -2.3% | 32.9% | -1.2 | 277 156 731 | -2.7% | 45.7% | -1 | 1.2% |
| YTD | 136 015 | -5.7% | 33.4% | -1.8 | 736 984 672 | 24.1% | 46.2% | 2.6 | -0.5% |
| MAT | 629 654 | 4.6% | 32.6% | -3.6 | 3 016 519 935 | 19.8% | 43.0% | -2.3 | 16.2% |
| REDUXIN FORTE | |||||||||
| WoW | 3 761 | 8.9% | 8.8% | -0.3 | 15 997 877 | 5.9% | 9.5% | -0.8 | 13.2% |
| MoM | 14 156 | 9.0% | 9.1% | 0.7 | 63 823 923 | 12.0% | 10.5% | 1.2 | 1.2% |
| YTD | 35 871 | 10.9% | 8.8% | 0.9 | 158 679 887 | 33.1% | 9.9% | 1.2 | -0.5% |
| MAT | 169 532 | 34.5% | 8.8% | 1.2 | 692 947 690 | 45.2% | 9.9% | 1.3 | 16.2% |
| SALVISAR | |||||||||
| WoW | 12 513 | 15.9% | 1.6% | 0.1 | 4 973 754 | 15.8% | 1.4% | 0.1 | 10.0% |
| MoM | 35 330 | 4.5% | 1.1% | 0.1 | 13 170 717 | 12.2% | 1.0% | 0.1 | -3.3% |
| YTD | 96 559 | -19.8% | 1.2% | -0.4 | 35 775 773 | -7.7% | 1.0% | -0.3 | 9.3% |
| MAT | 474 547 | -22.5% | 1.2% | -0.5 | 160 751 094 | -22.9% | 1.0% | -0.5 | 7.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 74 693 | 27.5% | 11.0% | 2.4 | 167 765 784 | 60.2% | 9.5% | 2.3 | -0.5% |
| BRAINMAX | 10 656 | 68.7% | 100.0% | 0 | 38 359 137 | 80.0% | 100.0% | 0 | 68.7% |
| GOLDLINE PLUS | 178 881 | 4.7% | 43.9% | 2.1 | 575 693 042 | 11.8% | 36.1% | -1.7 | -0.5% |
| MIGRENIUM | 132 585 | -0.7% | 0.5% | -0.1 | 37 136 297 | 54.5% | 0.6% | 0.1 | 23.7% |
| MODELAX-N | 339 513 | 62.4% | 22.8% | 5.5 | 137 979 492 | 106.7% | 14.0% | 4.1 | 23.1% |
| REDUXIN CAPS | 136 015 | -5.7% | 33.4% | -1.8 | 736 984 672 | 24.1% | 46.2% | 2.6 | -0.5% |
| REDUXIN FORTE | 35 871 | 10.9% | 8.8% | 0.9 | 158 679 887 | 33.1% | 9.9% | 1.2 | -0.5% |
| SALVISAR | 96 559 | -19.8% | 1.2% | -0.4 | 35 775 773 | -7.7% | 1.0% | -0.3 | 9.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 356 951 | 35.6% | 9.6% | 1.7 | 719 843 547 | 48.7% | 8.1% | 1.5 | 10.8% |
| BRAINMAX | 50 991 | 209.0% | 100.0% | NA | 178 051 328 | 229.3% | 100.0% | NA | NA |
| GOLDLINE PLUS | 877 004 | 22.2% | 45.4% | 2.2 | 2 752 620 342 | 31.3% | 39.2% | 1.5 | 16.2% |
| MIGRENIUM | 640 712 | 9.5% | 0.5% | 0 | 135 770 045 | 28.6% | 0.5% | 0 | 15.5% |
| MODELAX-N | 1 298 425 | 127.6% | 19.8% | 9 | 454 039 755 | 140.0% | 11.3% | 5.2 | 24.5% |
| REDUXIN CAPS | 629 654 | 4.6% | 32.6% | -3.6 | 3 016 519 935 | 19.8% | 43.0% | -2.3 | 16.2% |
| REDUXIN FORTE | 169 532 | 34.5% | 8.8% | 1.2 | 692 947 690 | 45.2% | 9.9% | 1.3 | 16.2% |
| SALVISAR | 474 547 | -22.5% | 1.2% | -0.5 | 160 751 094 | -22.9% | 1.0% | -0.5 | 7.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 050 | 11.7% | 10.4% | -0.8 | 17 971 195 | 9.8% | 8.9% | -0.8 | 20.3% |
| BRAINMAX | 1 030 | 13.3% | 100.0% | 0 | 3 599 867 | 7.1% | 100.0% | 0 | 13.3% |
| GOLDLINE PLUS | 19 276 | 16.7% | 45.0% | 1.4 | 61 208 525 | 18.0% | 36.2% | 0.8 | 13.2% |
| MIGRENIUM | 12 247 | 0.1% | 0.5% | 0 | 3 745 467 | 2.2% | 0.7% | 0 | 7.3% |
| MODELAX-N | 36 887 | -2.9% | 26.8% | -2 | 15 435 441 | -2.7% | 17.2% | -1.3 | 4.4% |
| REDUXIN CAPS | 14 174 | 11.4% | 33.1% | -0.5 | 79 486 350 | 16.5% | 47.0% | 0.5 | 13.2% |
| REDUXIN FORTE | 3 761 | 8.9% | 8.8% | -0.3 | 15 997 877 | 5.9% | 9.5% | -0.8 | 13.2% |
| SALVISAR | 12 513 | 15.9% | 1.6% | 0.1 | 4 973 754 | 15.8% | 1.4% | 0.1 | 10.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 171 | 8.3% | 11.0% | -0.1 | 65 772 614 | 9.3% | 9.5% | -0.1 | 9.6% |
| BRAINMAX | 3 949 | -7.8% | 100.0% | 0 | 14 394 547 | -5.2% | 100.0% | 0 | -7.8% |
| GOLDLINE PLUS | 68 306 | 1.9% | 43.8% | 0.3 | 217 517 575 | -1.1% | 35.9% | -0.2 | 1.2% |
| MIGRENIUM | 53 054 | 6.6% | 0.6% | 0.1 | 15 088 199 | 15.2% | 0.7% | 0.1 | -6.1% |
| MODELAX-N | 129 731 | 8.5% | 23.0% | 2.9 | 53 054 568 | 12.2% | 14.2% | 2.2 | -5.0% |
| REDUXIN CAPS | 51 307 | -2.3% | 32.9% | -1.2 | 277 156 731 | -2.7% | 45.7% | -1 | 1.2% |
| REDUXIN FORTE | 14 156 | 9.0% | 9.1% | 0.7 | 63 823 923 | 12.0% | 10.5% | 1.2 | 1.2% |
| SALVISAR | 35 330 | 4.5% | 1.1% | 0.1 | 13 170 717 | 12.2% | 1.0% | 0.1 | -3.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs